AT296324B - Verfahren zur Herstellung von neuen Xanthenderivaten - Google Patents

Verfahren zur Herstellung von neuen Xanthenderivaten

Info

Publication number
AT296324B
AT296324B AT806467A AT806467A AT296324B AT 296324 B AT296324 B AT 296324B AT 806467 A AT806467 A AT 806467A AT 806467 A AT806467 A AT 806467A AT 296324 B AT296324 B AT 296324B
Authority
AT
Austria
Prior art keywords
production
xanthene derivatives
new
new xanthene
derivatives
Prior art date
Application number
AT806467A
Other languages
English (en)
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL6711975A external-priority patent/NL150793B/xx
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Application granted granted Critical
Publication of AT296324B publication Critical patent/AT296324B/de
Priority claimed from US00352504A external-priority patent/US3855406A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/88—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0892—Compounds with a Si-O-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT806467A 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten AT296324B (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB05692/67A GB1181673A (en) 1966-09-02 1966-09-02 Derivatives of Xanthen and Thiaxanthen and Preparation Thereof
GB3938466 1966-09-02
NL6711975A NL150793B (nl) 1966-09-02 1967-08-31 Werkwijze voor het bereiden van een geneesmiddel met een werking tegen zweren en onder toetoepassing van deze werkwijze verkregen gevormde geneesmiddelen, alsmede werkwijze voor het bereiden van hiervoor geschikte geneeskrachtige xantheen- of thioxantheenderivaten.
US00352504A US3855406A (en) 1966-09-02 1973-04-19 Thiaxanthene derivatives useful for treating peptic ulcers

Publications (1)

Publication Number Publication Date
AT296324B true AT296324B (de) 1972-02-10

Family

ID=27448321

Family Applications (2)

Application Number Title Priority Date Filing Date
AT605769A AT289824B (de) 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen
AT806467A AT296324B (de) 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT605769A AT289824B (de) 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen

Country Status (9)

Country Link
US (6) US3558779A (de)
AT (2) AT289824B (de)
CA (1) CA962686A (de)
CH (1) CH491104A (de)
CS (2) CS186702B2 (de)
DE (1) DE1643244A1 (de)
ES (1) ES344599A1 (de)
FR (1) FR8016M (de)
GB (1) GB1181673A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886169A (en) * 1966-09-02 1975-05-27 Boots Co Ltd Xanthenyl and thiaxanthenyl semicarbazides
US3735327A (en) * 1972-01-07 1973-05-22 Cts Corp Variable resistance control
US3961069A (en) * 1975-04-23 1976-06-01 Smithkline Corporation Akenyl(or alkynyl) 9-xanthenyl ether compounds
US4005208A (en) * 1975-05-16 1977-01-25 Smithkline Corporation N-Heterocyclic-9-xanthenylamines
US3949076A (en) * 1975-05-29 1976-04-06 Smithkline Corporation N-(Heterocycl ic-alkyl)-9-xanthenylamines
US3980788A (en) * 1975-09-15 1976-09-14 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting gastric acid secretion
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
AU4515701A (en) 1999-12-02 2001-06-18 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
US8298661B2 (en) 2009-01-30 2012-10-30 W. R. Grace & Co.-Conn Waterproofing membrane
US8298662B2 (en) 2009-08-28 2012-10-30 W.R. Grace & Co.-Conn. Waterproofing membrane
WO2015039334A1 (en) * 2013-09-22 2015-03-26 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

Also Published As

Publication number Publication date
US3754005A (en) 1973-08-21
CS186702B2 (en) 1978-12-29
US3755594A (en) 1973-08-28
CH491104A (fr) 1970-05-31
ES344599A1 (es) 1969-04-16
CS186704B2 (en) 1978-12-29
US3855244A (en) 1974-12-17
US3558779A (en) 1971-01-26
FR8016M (de) 1970-08-03
DE1643244A1 (de) 1971-06-09
AT289824B (de) 1971-05-10
CA962686A (en) 1975-02-11
US3644420A (en) 1972-02-22
GB1181673A (en) 1970-02-18
US3755593A (en) 1973-08-28

Similar Documents

Publication Publication Date Title
CH501598A (de) Verfahren zur Herstellung von neuen Amidinoharnstoffen
AT272528B (de) Verfahren zur Herstellung von neuen Adenosin-Derivaten
AT277475B (de) Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten
CH499489A (de) Verfahren zur Herstellung von neuen Amino-monohalogen-phenyläthanolaminen
CH474522A (de) Verfahren zur Herstellung von neuen Imidazolderivaten
AT296324B (de) Verfahren zur Herstellung von neuen Xanthenderivaten
AT269855B (de) Verfahren zur Herstellung von neuen 5-Nitrofuran- bzw. 5-Nitrothiopen-Derivaten
AT277473B (de) Verfahren zur Herstellung von neuen Adenosin-Derivaten
AT277964B (de) Verfahren zur Herstellung von neuen Ketonitrilen
AT282577B (de) Verfahren zur Herstellung von neuen Fluorcyanoacrylaten
AT301766B (de) Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden
CH525893A (de) Verfahren zur Herstellung von neuen Benzomorphanderivaten
AT276421B (de) Verfahren zur Herstellung von neuen 4-Alkoxy-propylenharnstoff-bzw. -thioharnstoffderivaten
AT283610B (de) Verfahren zur Herstellung von neuen 4-Oxasteroiden
AT278035B (de) Verfahren zur Herstellung von neuen Benzodioxan-N-methylcarbamaten
CH487145A (de) Verfahren zur Herstellung von neuen Butoxy-dimethylbenzamiden
AT316541B (de) Verfahren zur Herstellung von neuen Isoindolderivaten
AT322569B (de) Verfahren zur herstellung von neuen thiobenzoylaminoalkylbenzolsulfonylharnstoffen
AT283349B (de) Verfahren zur herstellung von neuen 1-acyl-3-indolylcarbonsaeurederivaten
CH507226A (de) Verfahren zur Herstellung von neuen 3-Oxo-steroid-oximen
CH485000A (de) Verfahren zur Herstellung von Xanthenderivaten
AT269383B (de) Verfahren zur Herstellung von neuen Steroido-oxazolinen
AT271757B (de) Verfahren zur Herstellung von neuen Nitroöstratrienen
CH493529A (de) Verfahren zur Herstellung von neuen Chinazolinonderivaten
CH489524A (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee